New York, NY – June 24, 2026 – Accendra Health, Inc. (NYSE: ACH) has officially announced the expiration and final results of its recent Exchange Offers for its outstanding Senior Notes, achieving remarkable participation from investors. As of the expiration time on June 23, 2026, the company reported tenders from Eligible Holders amounting to nearly $1 billion in aggregate principal across two issues of its Senior Notes.

1. High Participation Rates for 2029 and 2030 Notes

Accendra Health's Exchange Offers targeted its 4.500% Senior Notes due 2029 and 6.625% Senior Notes due 2030, prompting a robust response from bondholders. The company received valid and unwithdrawn tenders amounting to approximately $478.3 million in 2029 Notes and $548.0 million in 2030 Notes. This translates to participation rates of 99.9% and 99.2% of the respective issues, demonstrating strong market confidence in Accendra's strategic initiatives.

2. Structure of the Exchange Offers

In connection with the Exchange Offers, Accendra Health plans to issue a total of $213.0 million in First Lien Notes and $698.1 million in Second Lien Notes. Additionally, the company will issue $326.25 million in First Lien Notes as part of a New Money Notes Issuance, culminating in a total of $539.25 million in First Lien Notes being made available to participants in the Exchange Offers.

The acceptance of these tendered notes is contingent upon meeting certain conditions outlined in the confidential offering memorandum dated May 22, 2026. These conditions are pivotal to the successful execution of the exchange, ensuring that the company adheres to regulatory requirements while maximizing the benefits for both Accendra and its bondholders.

3. Regulatory Considerations

It is important to note that the New Notes offered in the Exchange have not been registered with the Securities and Exchange Commission (SEC) under the Securities Act of 1933 or any other applicable securities laws. The Exchange Offers were exclusively extended to holders of Existing Notes classified as Eligible Holders, specifically targeting qualified institutional buyers and non-U.S. persons.

4. Advisory and Support

Accendra Health has enlisted Epiq Corporate Restructuring, LLC to serve as both the Exchange Agent and Information Agent for the Offers and Consent Solicitations. Furthermore, Ducera Securities LLC has been appointed as the financial advisor, providing expertise and guidance throughout the process.

5. About Accendra Health

Accendra Health, Inc. is recognized as a leading provider of health-related products and services, enhancing patient care beyond traditional hospital settings. With a mission to connect patients, providers, and insurers, the company emphasizes innovative solutions aimed at improving health outcomes, particularly for those managing chronic and complex conditions. Backed by the strength of its Apria and Byram brands, Accendra Health is committed to reshaping the landscape of home-based care.

Accendra's successful Exchange Offers reflect not only the company’s strategic financial management but also the confidence investors have in its future. With a solid backing and a clear vision, Accendra Health appears well-positioned to continue its mission of delivering quality health solutions across the nation.

Original press release